Pediatr. praxi. 2012;13(5):335-337

Neuroblastoma

MUDr.Simona Boráňová1, MUDr.Michal Žáčik2
Krajská nemocnice T. Bati Zlín, a. s.
1 Dětské oddělení

Casuistic presented of a 9-months infant admitted after acute urine retention, obstipation. By visual methods a major tumorose expansion

was diagnosed that impacted on larger part of the retroperitonea and a small pelvis from L4 to coccyx, infiltrating the intraspinal space

approximately from the L5 level caudally with a growth through the buttocks area on the right. Neuroblastom verified at the catchment

area Faculty hospital oncology department, medical treatment, corresponding therapy commenced.

Keywords: obstipation, urine retention, unrest

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Boráňová S, Žáčik M. Neuroblastoma. Pediatr. praxi. 2012;13(5):335-337.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adam Z, Krejčí M, Volíček J, et al. Speciální onkologie. Praha: Galén 2010: 353-354.
    2. Kushner, et al. Neuroblastoma - Linking a Comon Allele to a Rare Disorder. N Engl J Med 2008; 358: 2635-3637. Go to original source... Go to PubMed...
    3. Mazánek P, Bajčiová V, Šterba J, et al. Novinky v diagnostice a léčbě neuroblastomu. Onkológia 2008; 3(4): 257-261.
    4. Mališ J, Vícha A, Stejskalová E. Neuroblastom vysokého rizika. Lékařské listy 2003; 49(12): 10.
    5. Vícha A, Bedrníček J, Stejskalová E. Molekulární biologie neuroblastomu. Lékařské listy 2002; 49(12): 5.
    6. Peuchmar, et al. Revision of the International Neuroblastoma Pathology Classification. Cancer 2003; 98: 2274-2281. Go to original source... Go to PubMed...
    7. Cunsolo C Lo, Bicocchi MP, Petti AR, et al. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; surfoval correlates with chromosome 17 status. British Journal of Cancer 2000; 83(10): 1295-1300. Go to original source... Go to PubMed...
    8. Luttikhuis M, Powell JE, Rees S, et al. Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis. British Journal of Cancer 2001; 85: 531-537. Go to original source... Go to PubMed...
    9. Attiyeh EF, et al. Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma. N Engl J Med 2005; 353: 2243-2253. Go to original source... Go to PubMed...
    10. Maris, et al. Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene? Eur J Cancer 1997; 33(12): 1991-1996. Go to original source... Go to PubMed...
    11. White, et al. Detailed molecular analysis of 1p36 in neuroblastoma. Med Pediatr Oncol. 2001; 36(1): 37-41. Go to original source... Go to PubMed...
    12. Bown, et al. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol. 2001; 36(1): 14-19. Go to original source... Go to PubMed...
    13. Morowitz, et al. Detection of Single-Copy Chromosome 17q Gain in Human Neuroblastomas Using Real-Time Quantitative Polymerase Chain Reaction. Mod Pathol. 2003; 16(12): 1248-1256. Go to original source... Go to PubMed...
    14. Kuglík, et al. High resolution of comparative genomic hybridization improves detection of chromosomal aberrations with prognostic significance in neuroblastoma. European Journal of Human Genetics 2006; 14(Suppl 1): 184.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.